Shopping Cart
- Remove All
 
Your shopping cart is currently empty
PROTAC TTK degrader-1, a potent threonine tyrosine kinase (TTK) PROTAC degrader, demonstrates DC50 values of 1.7 nM in COLO-205 cells and 5.8 nM in HCT-116 cells, indicating effective target degradation. Furthermore, it shows anticancer efficacy in a xenograft mouse model with COLO-205 human colorectal cancer cells [1].

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 5 mg | Inquiry | Backorder | |
| 50 mg | Inquiry | Backorder | 
| Description | PROTAC TTK degrader-1, a potent threonine tyrosine kinase (TTK) PROTAC degrader, demonstrates DC50 values of 1.7 nM in COLO-205 cells and 5.8 nM in HCT-116 cells, indicating effective target degradation. Furthermore, it shows anticancer efficacy in a xenograft mouse model with COLO-205 human colorectal cancer cells [1].  | 
| In vitro | Compound 8e, a PROTAC TTK degrader-1, demonstrates antiproliferative activity against cancer cells at concentrations ranging from 0 to 10 μM over a 96-hour period [1].  | 
| In vivo | PROTAC TTK degrader-1 administered intraperitoneally (IP) at a single dose of 10 mg/kg exhibits satisfactory pharmacokinetic profiles [1]. When administered IP at doses of 10 or 20 mg/kg once daily over a 16-day period, PROTAC TTK degrader-1 substantially decreases TTK protein levels and demonstrates significant tumor growth inhibition [1].  | 
| Molecular Weight | 855.98 | 
| Formula | C47H53N9O7 | 
| Cas No. | 2953426-43-0 | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.